Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
radiopharmaceuticals
Pharma
Proposed nuclear rules threaten Novartis’ Pluvicto
Experts warn that a draft guide by nuclear authorities contains rigid assumptions that could add barriers to patient access to radiopharmaceuticals.
Angus Liu
Oct 6, 2026 9:00am
Radiopharmaceutical player NorthStar locks up $185M
Sep 30, 2026 9:00am
FDA approves first radioligand equivalent
Sep 15, 2026 8:38am
BMS to build $173M radiopharmaceutical plant in Indiana
Aug 27, 2026 2:45pm
ITM cancer drug spurned by FDA over manufacturing qualms
Aug 10, 2026 11:25am
Fierce Biotech
Curium strikes up to $8B deal for radiopharma rival Lantheus
Aug 3, 2026 2:20pm